Unlike earlier weight-management medicines, retatrutide simultaneously targets three distinct hormone receptors: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor
However, semaglutide is not currently FDA-approved for treating alcohol use disorder, and research is still limited by small sample sizes, short study durations, and a focus on people with obesity or moderate drinking patterns
Assessment should include medication review to identify other constipating agents, digital rectal examination when indicated, and consideration of abdominal imaging if obstruction is suspected
CD specials Wells Fargo offers three term lengths for its CD specials: 4, 7, and 11 months
Meet the expert : Gilberto Lopes, MD, chief of the division of Medical Oncology with Sylvester Comprehensive Cancer Center, part of the University of Miami Health System